Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Temozolomide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Temozolomide 100mg capsules
0801050Y0AAAAAA
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | 1 |
|
Temozolomide 20mg capsules
0801050Y0AAADAD
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | 1 |
|
Temozolomide 5mg capsules
0801050Y0AAACAC
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | 1 |
|
Temodal 100mg capsules
0801050Y0BBAAAA
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 140mg capsules
0801050Y0BBAEAE
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 180mg capsules
0801050Y0BBAFAF
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 20mg capsules
0801050Y0BBADAD
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 250mg capsules
0801050Y0BBABAB
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temodal 5mg capsules
0801050Y0BBACAC
|
Temodal | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 100mg capsules
0801050Y0BCACAA
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 140mg capsules
0801050Y0BCADAE
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 180mg capsules
0801050Y0BCAEAF
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 20mg capsules
0801050Y0BCABAD
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 250mg capsules
0801050Y0BCAFAB
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temomedac 5mg capsules
0801050Y0BCAAAC
|
Temomedac | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temozolomide 140mg capsules
0801050Y0AAAEAE
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temozolomide 180mg capsules
0801050Y0AAAFAF
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temozolomide 250mg capsules
0801050Y0AAABAB
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.